Gout Is an Autoinflammatory Metabolic Disease

On Monday, Nov. 14, Michael Pillinger, MD, will moderate the session Gout Is an Autoinflammatory Metabolic Disease at ACR Convergence 2022. This session will address the autoinflammatory nature of gout and highlight it as an IL-1β-mediated diseases. Increasing knowledge on the inflammatory mechanisms of gout has implications for disease management. These engaging talks will review the state of the science regarding the immunology, clinical manifestations, and treatments of acute gout flares and anti-inflammatory prophylaxis as an integral part of gout treatment.

First up, Charles Dinarello will present IL-1β Induces Gouty Inflammation. Then Naomi Schlesinger, MD, will present Treatment of Acute and Chronic Gouty Inflammation: an Update.

Watch this space for our full report on this session.

“Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

From the first substantial argument in the 19th century that uric acid played a role in gout, it took about 100 years for the medical community to accept its role in triggering acute inflammatory gout attacks. Two papers, both published in 1962, helped demonstrate the link between uric acid and acute gout attacks, quickly opening…

Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care

Gout Is an Autoinflammatory Metabolic Disease

Difficult Gout

Understanding the Role of Uric Acid in Gout

Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium

Related Articles